*
*
Scoring Key: 5=Strongly Agree 4= Somewhat agree 3=Neither agree nor disagree 2= Somewhat disagree 1=Strongly disagree NA=Not applicable
54321NA
The skills learned in this CME course enhanced my professional competence.
The skills learned in this CME course will be applied in the treatment of my patients
*
5 = High level of confidence 4 = Moderately high level of confidence 3 = Average level of confidence 2 = Low level of confidence 1 = No level of confidence
54321
Utilize the latest therapeutic advance for the treatment of AL amyloidosis.
Evaluate the eligibility criteria of ongoing clinical trials for AL amyloidosis to facilitate appropriate patient enrollment or referral.
*
Scoring Key: 5=Strongly satisfied 4= Somewhat satisfied 3=Neither satisfied nor dissatisfied 2= Somewhat dissatisfied 1=Strongly dissatisfied
54321
Explain the pathophysiology of the plasma cell disorder AL amyloidosis to enhance understanding of disease mechanisms.
Analyze recent data on therapeutic advances and evolving practice standards in AL amyloidosis and integrate this information into the selection of optimal systemic therapies for patients.
Implement strategies to enhance patient-centered care.
Evaluate the design and eligibility criteria of ongoing clinical trials for AL amyloidosis and facilitate appropriate patient enrollment or referral.
*
*
*
*